Genetic aberrations in GBM, including EGFR and PTEN alterations, leading to a dysfunction of the PI3K/Akt/mTOR pathway with effects on cell proliferation, metabolism, apoptosis, motility, and angiogenesis in GBM. This evidence concerns the gene EGFR and glioblastoma.